By Nick Paul Taylor
A pair of phase 3 clinical trials of Arcutis Biotherapeutics’ roflumilast cream have met their primary endpoints, teeing the company up to seek FDA approval in plaque psoriasis in the second half of the year.
read more
By Nick Paul Taylor
BiomX has reported top-line findings from a phase 1a clinical trial of its orally administered phage therapy candidate BX002. The study provided early evidence BiomX can get the high concentrations of viable phage to the gastrointestinal tract needed to make oral administration a feasible option.
read more
By Nick Paul Taylor
Tiziana Life Sciences has reported data from a small clinical trial of a nasally administered antibody in COVID-19 patients. The study provided early evidence that the anti-CD3 human monoclonal antibody can improve outcomes in people infected with the pandemic coronavirus.
read more
By Eric Sagonowsky
Novo Nordisk is off and running with its launch for oral semaglutide, a Type 2 diabetes med carrying blockbuster expectations. But the company also sees potential new uses for its oral delivery platform, and it's bolstering its manufacturing network to support its forays in that direction.
read more
Sponsored By: Medidata, a Dassault Systèmes company
8 parameters to optimize your “Path to Virtualization” across site- and patient-centric capabilities in this Sponsor Edition eBook.
Sponsored By: LabVantage Solutions
Uncover the real impact of “digital transformation” with practical advice to help you plan your own transformative journey to a harmonized digital ecosystem.
Sponsored By: Acorn AI, a Medidata Company
Acorn AI has developed a flexible and scalable Commercial Data Model that provides pharmaceutical companies with the data-driven insights required to respond to the industry’s ever-changing landscape. Download the whitepaper to learn how Acorn AI’s intuitive data model enables launch success and more.
Sponsored by: Catalent
Learn about drug product process development challenges and risks, the difference between innovator and biosimilar drug product process development, and more during the drug product process development phase.
Sponsored by: Catalent
In this webinar, pharmaceutical scientists present real-life examples of challenges they’ve overcome in the transfer of oral small molecules from a dedicated early-phase development site to a dedicated late-phase manufacturing site.
